QuiVad

Home / Funds / Voleon Capital Management LP

Voleon Capital Management LP

The short positions this fund discloses today, across every market.

Follow

Open short positions, the heaviest first.
IssuerMarket% of capitalSince
Zealand Pharma A/SDenmark1.11%May 19, 2026
B&M European Value Retail S.A.Germany0.79%April 20, 2026
Oryzon Genomics, S.A.Spain0.63%July 3, 2026
Gubra A/SDenmark0.59%March 23, 2026
Lang & Schwarz AktiengesellschaftGermany0.59%February 2, 2022
Tubacex, S.A.Spain0.59%June 30, 2026
Medigene AGGermany0.55%December 4, 2017
Atos GroupFrance0.50%July 21, 2026

History of disclosures

6109 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
September 22, 2020Aurelius Equity Opportunities SE & CO. KGAAGermany1.20%still open
September 22, 2020CGGFrance0.88%still open
September 22, 2020ViridienFrance0.88%November 18, 2020
September 22, 2020Cell Impact AB (publ)Sweden0.70%still open
September 22, 2020Byggmax Group ABSweden0.61%still open
September 22, 2020Clas Ohlson AktiebolagSweden0.52%still open
September 22, 2020Deutsche Euroshop AGGermany0.50%still open
September 21, 2020NovacytFrance1.18%October 5, 2020
September 21, 2020Corestate Capital HoldingGermany1.11%still open
September 21, 2020SNP Schneider-Neureither & Partner SEGermany0.71%still open
September 21, 2020Cell Impact AB (publ)Sweden0.63%still open
September 21, 2020ClaranovaFrance0.51%October 15, 2020
September 21, 2020Loomis ABSweden0.50%still open
September 18, 2020Kier Group PLCUnited Kingdom0.60%still open
September 18, 2020Byggmax Group ABSweden0.52%still open
September 18, 2020Koninklijke BAM Groep N.V.Netherlands0.50%still open
September 17, 2020Fugro N.V.Netherlands1.78%still open
September 17, 2020Metro Bank PLCUnited Kingdom1.18%still open
September 17, 2020Aurelius Equity Opportunities SE & CO. KGAAGermany1.10%still open
September 17, 2020K+S AktiengesellschaftGermany0.74%still open
September 17, 2020CGGFrance0.70%still open
September 17, 2020ViridienFrance0.70%November 18, 2020
September 17, 2020Oncopeptides ABSweden0.00%still open
September 17, 2020SAS ABSweden0.00%still open
September 16, 2020Fugro N.V.Netherlands1.96%still open
September 16, 2020Corestate Capital HoldingGermany1.00%still open
September 16, 2020Pharming Group N.V.Netherlands0.68%still open
September 16, 2020CGGFrance0.65%still open
September 16, 2020ViridienFrance0.65%November 18, 2020
September 16, 2020Oncopeptides ABSweden0.54%still open
September 15, 2020Fugro N.V.Netherlands2.08%still open
September 15, 2020Aurelius Equity Opportunities SE & CO. KGAAGermany1.02%still open
September 15, 2020Indra Sistemas, S.A.Spain0.60%still open
September 15, 2020Oncopeptides ABSweden0.60%still open
September 15, 2020VallourecFrance0.58%February 19, 2021
September 15, 2020Bonava AB (publ)Sweden0.50%still open
September 14, 2020Metro Bank PLCUnited Kingdom1.26%still open
September 14, 2020VallourecFrance0.69%February 19, 2021
September 14, 2020Wienerberger AGAustria0.49%still open
September 14, 2020ChargeursFrance0.36%still open
September 14, 2020Compagnie Chargeurs InvestFrance0.36%September 16, 2020
September 14, 2020Fingerprint Cards ABSweden0.00%still open
September 11, 2020GenfitFrance1.17%November 9, 2020
September 11, 2020Corestate Capital HoldingGermany0.90%still open
September 11, 2020ChargeursFrance0.54%still open
September 11, 2020Compagnie Chargeurs InvestFrance0.54%September 16, 2020
September 10, 2020Aurelius Equity Opportunities SE & CO. KGAAGermany0.90%still open
September 10, 2020VallourecFrance0.76%February 19, 2021
September 10, 2020ChargeursFrance0.70%still open
September 10, 2020Compagnie Chargeurs InvestFrance0.70%September 16, 2020

The funds short on the same companies

Download as CSV

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Voleon Capital Management LP, data as at July 21, 2026, https://www.quivad.com/detenteur/voleon-capital-management-lp?page=76